Zusammenfassung
Eine radikale Hysterektomie ist als Primärtherapie typischerweise indiziert beim Zervixkarzinom Stadium IB oder IIA, beim Endometriumkarzinom Stadium II (mit tiefer Stromainvasion), beim Vaginalkarzinom (oberes Vaginaldrittel) und bei anderen selteneren Malignome des Uterus, der Cervix uteri (z. B. Sarkome) und des oberen Vaginaldrittels. Das Zervixkarzinom stellt dabei die häufigste Indikation für die Durchführung einer radikalen Hysterektomie dar. Deshalb wird die stadienbezogene Therapie des Zervixkarzinoms beschrieben. Graphische Algorithmen sollen bei der Entwicklung des therapeutischen Konzepts helfen.
Abstract
Radical hysterectomy is performed as primary therapy for stage IB or IIA cancer of the cervix, stage II adenocarcinoma of the endometrium (with deep stromal invasion), upper vaginal carcinoma, uterine or cervical sarcomas, and other rare malignancies confined to the cervix, uterus, and/or upper vagina. Cervical cancer, however, represents the most common indication for radical hysterectomy. Treatment of cervical cancer is stage-dependent. Algorithms can help physicians develop an appropriate therapeutic approach.
This is a preview of subscription content, log in via an institution to check access.
Literatur
Ishii K et al. (2001) Ovarian function after radical hysterectomy with ovarian preservation for cervical cancer. J Reprod Med 46: 347–352
Piver MS, Rutledge F, Smith JP (1974) Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol 44: 265–272
Landoni F et al. (1997) Randomised study of radical surgery versus radiotherapy for stage Ib–IIa cervical cancer. Lancet 350: 535–540
Kolben M et al. (2004) Operative Therapie des Zervixkarzinoms. Manual Zervixkarzinom. Zuckschwerdt, München
Committee on Practice Bulletins-Gynecology (2002) ACOG practice bulletin. Diagnosis and treatment of cervical carcinomas, number 35, May 2002. Obstet Gynecol 99: 855–867
Hertel H et al. (2002) Laparoscopic staging compared with imaging techniques in the staging of advanced cervical cancer. Gynecol Oncol 87: 46–51
Covens A et al. (1999) Is radical trachelectomy a safe alternative to radical hysterectomy for patients with stage IA-B carcinoma of the cervix? Cancer 86: 2273–2279
Marchiole P et al. (2007) Oncological safety of laparoscopic-assisted vaginal radical trachelectomy (LARVT or Dargent’s operation): a comparative study with laparoscopic-assisted vaginal radical hysterectomy (LARVH). Gynecol Oncol 106: 132–141
Morice P et al. (2004) First case of a centropelvic recurrence after radical trachelectomy: literature review and implications for the preoperative selection of patients. Gynecol Oncol 92: 1002–1005
Bremer GL et al. (1992) Early stage cervical cancer: aborted versus completed radical hysterectomy. Eur J Obstet Gynecol Reprod Biol 47: 147–151
Sevin BU, Nadji M, Lampe B et al. (1995) Prognostic factors of early stage cervical cancer treated by radical hysterectomy. Cancer (Suppl 10) 76: 1978–1986
Kenter GG et al. (2000) The case for completing the lymphadenectomy when positive lymph nodes are found during radical hysterectomy for cervical carcinoma. Acta Obstet Gynecol Scand 79: 72–76
Ayhan A, Tuncer ZS (1991) Radical hysterectomy with lymphadenectomy for treatment of early stage cervical cancer: clinical experience of 278 cases. J Surg Oncol 47: 175–177
Green J et al. (2005) Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. Cochrane Database Syst Rev 3: CD002225
Lehman M, Thomas G (2001) Is concurrent chemotherapy and radiotherapy the new standard of care for locally advanced cervical cancer? Int J Gynecol Cancer 11: 87–99
Peters WA 3rd et al. (2000) Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 18: 1606–1613
Benedetti-Panici P et al. (2002) Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study. J Clin Oncol 20: 179–188
Rotman M et al. (1995) Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79–20. JAMA 274: 387–393
Cosin JA et al. (1998) Pretreatment surgical staging of patients with cervical carcinoma: the case for lymph node debulking. Cancer 82: 2241–2248
Lai CH et al. (2003) Randomized trial of surgical staging (extraperitoneal or laparoscopic) versus clinical staging in locally advanced cervical cancer. Gynecol Oncol 89: 160–167
Marnitz S et al. (2005) Is there a benefit of pretreatment laparoscopic transperitoneal surgical staging in patients with advanced cervical cancer? Gynecol Oncol 99: 536–544
Hacker NF, Wain GV, Nicklin JL (1995) Resection of bulky positive lymph nodes in patients with cervical carcinoma. Int J Gynecol Cancer 5: 250–256
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dannecker, C., Hantschmann, P. & Friese, K. Stadienbezogene Therapie des Zervixkarzinoms. Gynäkologe 41, 349–354 (2008). https://doi.org/10.1007/s00129-008-2132-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00129-008-2132-x